On Sep 9, 2021 Mammoth Biosciences closed a Series D round and raised $150,000,000 from Decheng Capital, Foresite Capital, Greenspring Associates, Mayfield Fund, NFX, Plum Alley Investments, Redmile Group, Senator Investment Group, Sixth Street, featuring lead investors Redmile Group.

About the company: Mammoth Biosciences is located at United States, North America.
“”

Company website: http://www.mammoth.bio